Cargando…
Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis
Myasthenia gravis (MG) is a neuromuscular junction disease with a complex pathophysiology and clinical variation for which no clear biomarker has been discovered. We hypothesized that because changes in gut microbiome composition often occur in autoimmune diseases, the gut microbiome structures of p...
Autores principales: | Chang, Che-Cheng, Liu, Tzu-Chi, Lu, Chi-Jie, Chiu, Hou-Chang, Lin, Wei-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565662/ https://www.ncbi.nlm.nih.gov/pubmed/37829445 http://dx.doi.org/10.3389/fmicb.2023.1227300 |
Ejemplares similares
-
Exploring the Gut Microbiome in Myasthenia Gravis
por: Thye, Angel Yun-Kuan, et al.
Publicado: (2022) -
Utilization of Decision Tree Algorithms for Supporting the Prediction of Intensive Care Unit Admission of Myasthenia Gravis: A Machine Learning-Based Approach
por: Chang, Che-Cheng, et al.
Publicado: (2022) -
Altered Gut Microbiota in Myasthenia Gravis
por: Qiu, Dongxu, et al.
Publicado: (2018) -
Altered gut microbiota and metabolites in untreated myasthenia gravis patients
por: Ding, Xiao-Jun, et al.
Publicado: (2023) -
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study
por: Verhasselt, Hedda Luise, et al.
Publicado: (2023)